First Insight Into the Fluoroquinolone and Aminoglycoside Resistance of Multidrug-Resistant Mycobacterium tuberculosis in Saudi Arabia

The American Journal of Tropical Medicine and Hygiene
Bright Varghese, Sahal Al-Hajoj

Abstract

AbstractIn Saudi Arabia, there were no nationwide screening studies conducted so far to determine the aminoglycoside and fluoroquinolone resistance among multidrug-resistant tuberculosis (MDR-TB) isolates. Therefore, as the first attempt in the country, a retrospective analysis has been conducted on a nationwide collection of 2,956 M. tuberculosis clinical isolates screened with phenotypic drug susceptibility testing to define MDR-TB. Enrolled MDR-TB isolates were subjected to second-line drug susceptibility testing, detection of mutations conferring resistance to aminoglycosides and fluoroquinolone, followed by 24-loci mycobacterial interspersed repetitive unit-variable number of tandem repeat typing and spoligotyping. Overall, 83 isolates were identified as MDR-TB, and 13 (15.7%) isolates showed resistance to second-line drugs. Moxifloxacin (low level) showed higher resistant rates (10.8%) followed by ofloxacin (7.2%), capreomycin (3.6%), kanamycin (3.6%), and amikacin (2.4%). Overall fluoroquinolone resistance was 12%, whereas aminoglycoside resistance was 7.2%. Predominant mutations conferring resistance to fluoroquinolone were found in gyrA A90V and D94G, whereas aminoglycoside resistance was observed only with rrs gene A1...Continue Reading

References

Feb 1, 1993·Research in Microbiology·A KochiK Styblo
Jan 25, 2000·Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·S Ramaswamy, J M Musser
Mar 26, 2003·Antimicrobial Agents and Chemotherapy·Srinivas V RamaswamyEdward A Graviss
Jan 28, 2005·Antimicrobial Agents and Chemotherapy·Courtney E MausThomas M Shinnick
Jul 29, 2005·Antimicrobial Agents and Chemotherapy·Courtney E MausThomas M Shinnick
Jun 8, 2007·Emerging Infectious Diseases·N Sarita ShahJ Peter Cegielski
Jun 30, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Carol Dukes HamiltonGwen Huitt
Jul 10, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Yong Soo KwonWon-Jung Koh
Dec 23, 2008·American Journal of Respiratory and Critical Care Medicine·Chi Chiu Leung, Wing Wai Yew
Apr 21, 2009·Lancet·Abigail WrightUNKNOWN Global Project on Anti-Tuberculosis Drug Resistance Surveillance
Jun 2, 2011·Proceedings of the National Academy of Sciences of the United States of America·Wenjing ChenSylvie Garneau-Tsodikova
Feb 14, 2012·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Bright VargheseSahal Al-Hajoj
Mar 14, 2012·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·X LiX Ma
Mar 28, 2012·Antimicrobial Agents and Chemotherapy·Ajay PoudelYasuhiko Suzuki
Aug 25, 2012·Lung India : Official Organ of Indian Chest Society·Sarala MenonRenu Bharadwaj
Dec 19, 2012·Trends in Genetics : TIG·Borna MüllerSebastien Gagneux
Mar 6, 2013·Antimicrobial Agents and Chemotherapy·Sahal Al-HajojZiad Memish
Jul 12, 2014·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Bright VargheseSahal Al-Hajoj
Oct 16, 2015·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·Y Zhang, W-W Yew

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.